Madison, Wisconsin – May 16, 2016 – Propeller, the leading digital health solution for respiratory medicine today announced the the company has been recognized as the recipient of the American Telemedicine Association’s 2016 President’s Award for Innovation in Remote Healthcare Award.
According to the ATA, the President’s Awards for the Advancement of Telemedicine are provided annually in order to recognize substantial contributions toward the advancement of telemedicine. The award recognizes advances in the telemedicine through one or more of the following categories: innovative new technology development or adaptation, novel use of technology leading to innovative health applications and social services support at the individual or community level, creative strategies for removing barriers to implementation and adoption, innovative approaches to fostering partnerships and collaboration, innovative ways responding to needs of end-users, and new ideas, concepts, formulation and paradigms, and new ways of thinking “outside the box”.
Since 2012, Propeller’s digital programs for asthma and COPD have been used by more than 40 of the nation’s leading healthcare systems and insurers to help improve management and outcomes from chronic respiratory disease. “Nemours Children’s Health System is proud to partner with Propeller and leverage their award-winning digital health platform to improve outcomes for our pediatric patients living with asthma” stated Paul Rosen, M.D., Clinical Director of Service and Operational Excellence, Nemours Children’s Health System.
The award will be presented at ATA’s 21st Annual International Conference & Tradeshow in Minneapolis, Minnesota on Tuesday, May 17th during the morning’s opening plenary session. The annual event is the world’s largest and most comprehensive meeting focused on telemedicine, digital, connected and mobile health attended by an estimated 6,000 attendees from traditional medicine, academic medical centers, technology and telecommunications companies, e-health, medical societies, government and others.
In addition to recognition from the ATA, the leading international resource and advocate promoting the use of advanced remote medical technologies, Propeller is appreciative of continuing support from partners.
Founded in 2010, Propeller is the leading provider of an FDA-cleared digital health platform that helps reduce the cost of care while delivering better quality of life for individuals with chronic respiratory disease. Propeller provides better engagement, communication, and more insightful and personalized care. Backed by Safeguard Scientifics (NYSE: SFE), Social Capital, California HealthCare Foundation, Kapor Capital and other investors, Propeller has been used by patients with asthma or COPD in over 40 commercial programs across the US at major healthcare systems, payers, employers and other commercial partners. The company has been recognized as the recipient of the American Telemedicine Association’s 2016 President’s Award for Innovation in Remote Healthcare and as one of the top “Fierce 15” medical device companies in 2015 by FierceMedicalDevices. Recognition also includes TEDMED Innovation Showcase, White House Champion of Change, and Bluetooth Breakthrough Product awards. Visit http://propellerhealth.com/contact/ to request more information.